-
2012 | May | Volume 6 | Issue 4 | Page 704 Selvamani Backianathan, Patricia Sebastian, Marie Therese M., Raju Titus Chacko, Subhashini John. Very Late Solitary Metastasis for Renal Cell Carcinoma [Internet].2012 May [Cited December15, 2020];6(4):704-706. Available from:http://www.jcdr.net//back_issues.asp?issn=0973-709x&year=2012&month=May&volume=6&issue=4&page=704&id=2110
-
Patricia S, Saikat D, Rajesh B, Rajesh I, Selvamani B, Subhashini J. Rare Cause of Stricture Esophagus-Sarcoma: A Case Report and Review of the literature. Case Rep Gastrointest Med. 2011;2011:192423. doi: 10.1155/2011/192423. Epub 2011 Oct 13. PMID: 22606414; PMCID: PMC3350176.
-
Sebastian P, Govindaraj R, Burad D, Balakrishnan R, Backianathan S, John S Radiotherapy for Kasabach-Merritt (KM) phenomenon in an adult patient with benign vascular neoplasm - A case report Southeast Asian J Case Rep Rev 2013;2(6):505–11
-
Darapu A, Balakrishnan R, Sebastian P, Hussain MR, Ravindran P, John S. Is the Deep Inspiration Breath-Hold Technique Superior to the Free Breathing Technique in Cardiac and Lung Sparing while Treating both Left-Sided Post-Mastectomy Chest Wall and Supraclavicular Regions? Case Rep Oncol. 2017 Jan 16;10(1):37-51. doi: 10.1159/000453607. PMID: 28203163; PMCID: PMC5301112.
-
Sebastian P, Balakrishnan R, Yadav B, John S. Outcome of radiotherapy for pituitary adenomas. Rep Pract Oncol Radiother. 2016 Sep-Oct;21(5):466-72. doi: 10.1016/j.rpor.2016.06.002. Epub 2016 Jul 15. PMID: 27489518; PMCID: PMC4950161.
-
Koti KA, Backianathan S, Sebastian P, Matthew LG, Raam M, Masih D. A Rare Case of Gastric Metastasis in Ewing's Sarcoma of the Femur. Case Rep Oncol Med. 2019 May 14;2019:2870302. doi: 10.1155/2019/2870302. PMID: 31218087; PMCID: PMC6537017. Link
-
Varghese SS, Sebastian P, Joseph V, Chacko G, Backianathan S. An unusually long survival of a patient with glioblastoma of spinal cord: a case report. J Clin Diagn Res. 2014 Apr;8(4):QD01-3. doi: 10.7860/JCDR/2014/8486.4218. Epub 2014 Apr 15. PMID: 24959488; PMCID: PMC4064906. Link
-
Chatterjee S, Chakraborty S; HYPORT Adjuvant Author Group. Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)-study protocol for a multicentre, randomized phase III trial. Trials. 2020 Sep 30;21(1):819. doi: 10.1186/s13063-020-04751-y. PMID: 32998747; PMCID: PMC7526182. Link
-
Joel A, Georgy JT, Thumaty DB, John AO, Chacko RT, Rebekah G, Sigamani E, Chandramohan J, Manipadam MT, Cherian AJ, Abraham DT, Jacob PM, Sebastian P, Backianathan S, Singh A. Neoadjuvant chemotherapy with biosimilar trastuzumab in human epidermal growth factor receptor 2 overexpressed non-metastatic breast cancer: patterns of use and clinical outcomes in India. Ecancermedicalscience. 2021 Mar 19;15:1207. doi: 10.3332/ecancer.2021.1207. PMID: 33912232; PMCID: PMC8057782.
-
Sebastian, P., Siddique, S. K., Varghese, S. S., Prabhu, A. J., Titus, V. T. K., Backianathan, S. and Nayak, S. Dermatofibrosarcoma protuberans - The impact of radiation therapy: A single institution series Journal of Radiotherapy in Practice; 2018, 17 (4): 441-446 Link
-
Sebastian P, Siddique SK,Varghese SS, Prabhu AJ, Titus VTK,Backianathan S, Nayak S. (2018) Dermatofibrosarcoma protuberans – the impact of radiation therapy: a single institution series. Journal of Radiotherapy in Practice page 1 of 6. doi: 10.1017/S1460396918000109
-
Rajkrishna B, Balakrishnan R, Raam M, Santhosh Raj A, Sebastian P, Selvamani B. Aggressive malignant phyllodes tumor of breast with omental metastases - A case report. Breast Dis. 2021;40(4):287-291. doi: 10.3233/BD-201054. PMID: 34420938.
-
Venkatasai J, Balakrishnan R, Rajkrishna B, Sebastain P, John RR, Vanjare HA, Prabhu K, Nair B, Mathew LG, Backianathan S. A pragmatic diagnostic approach to primary intracranial germ cell tumors and their treatment outcomes. CNS Oncol. 2021 Nov 22;10(4):CNS79. doi: 10.2217/cns-2021-0012. Epub ahead of print. PMID: 34806399; PMCID: PMC8610002.
-
Rafic KM, Patricia S, Timothy Peace B, Sujith CJ, Selvamani B, Ravindran PB. Dosimetric and clinical advantages of adapting the DIBH technique to hybrid solitary dynamic portal radiotherapy for left-sided chest-wall plus regional nodal irradiation. Med Dosim. 2020 Autumn;45(3):256-263. doi: 10.1016/j.meddos.2020.01.002. Epub 2020 May 1. PMID: 32362370.
-
George B, Balakrishnan R, S P, Lionel S, Selvarajan S, Devasia AJ, Korula A, Lakshmi KM, Aboobacker FN, Kulkarni U, Godson HF, Raj JS, Abraham A, Backianathan S, Mathews V. Total marrow lymphoid irradiation and cyclophosphamide is associated with low toxicity and good outcomes in patients undergoing hematopoietic stem cell transplantation for acute lymphoblastic leukemia and chronic myeloid leukemia in lymphoid blast crises - A phase I study. Clin Transplant. 2023 May 5:e15010. doi: 10.1111/ctr.15010. Epub ahead of print. PMID: 37144852.
-
George B, Balakrishnan R, S P, Lionel S, Selvarajan S, Devasia AJ, Korula A, Lakshmi KM, Aboobacker FN, Kulkarni U, Godson HF, Raj JS, Abraham A, Backianathan S, Mathews V. Total marrow lymphoid irradiation and cyclophosphamide is associated with low toxicity and good outcomes in patients undergoing hematopoietic stem cell transplantation for acute lymphoblastic leukemia and chronic myeloid leukemia in lymphoid blast crises - A phase I study. Clin Transplant. 2023 Sep;37(9):e15010. doi: 10.1111/ctr.15010. Epub 2023 May 5. PMID: 37144852. Link
-
Chakraborty S, Chatterjee S, Chakraborty S, Backianathan S, Lal P, Gupta S, Ahmed R, Misra S, Solomon P, Balakrishan R, Bhushal S, Guha D, Maria Das KJ, Mahata A, Mandal S, Kumari A, Finlay Godson H, Ganguly S, Kumari A, Shamsudden C, Dinesh M, Dey D, Chatterjee S. HYPORT Adjuvant Acute toxicity and patient dosimetry quality assurance results- Interim Analysis. Radiother Oncol. 2022 Jul 8:S0167-8140(22)04189-5. doi: 10.1016/j.radonc.2022.07.003. Epub ahead of print. PMID: 35817323.
-
Balakrishnan R, Sebastian P, Zaveri GR Radiotherapy for spinal metastasis: A narrative review. Indian Spine Journal; 2022, 5 (2): 185-192 Link
-
Chakraborty S, Chatterjee S; Hyport Adjuvant Author Group Hyport Adjuvant Author Group. HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results - Interim analysis. Radiother Oncol. 2022 Sep;174:59-68. doi: 10.1016/j.radonc.2022.07.003. Epub 2022 Jul 9. PMID: 35817323.
-
Koti KA, Backianathan S, Sebastian P, Matthew LG, Raam M, Masih D. A Rare Case of Gastric Metastasis in Ewing's Sarcoma of the Femur. Case Rep Oncol Med. 2019 May 14;2019:2870302. doi: 10.1155/2019/2870302. PMID: 31218087; PMCID: PMC6537017.
-
Ganesh S, Jasper A, Backianathan S, Moorthy RK, Balakrishnan R, Sebastian P, Moses V, Godson HF, Keshava SN, Rajshekhar V. Correlation Between Post-Radiosurgery Perinidal Hyperintensity and AVM Obliteration Following LINAC-Based Stereotactic Radiosurgery. World Neurosurg. 2023 Oct;178:e189-e201. doi: 10.1016/j.wneu.2023.07.032. Epub 2023 Jul 15. PMID: 37454908.
-
Joseph J, Raju KP, Jonathan GE, B R, Ganesh S, S P, Godson HF. Hypofractionated stereotactic radiotherapy in Spetzler Martin grades 4 and 5 arteriovenous malformations in the pediatric population: Is it a viable alternative? Childs Nerv Syst. 2023 Dec 10. doi: 10.1007/s00381-023-06244-0. Epub ahead of print. PMID: 38071636. Link
-
Singh A, Georgy JT, Joel A, Thumaty DB, John AO, Ramnath N, George TK, Sharma P, Patole S, Rebekah G, Sigamani E, Manipadam MT, Cherian AJ, Abraham DT, Paul MJ, Balakrishnan R, Sebastian P, Backianathan S, Chacko RT. Dose-Dense Docetaxel-Cyclophosphamide and Epirubicin-Cisplatin(ddDCEP): Analysis of an Alternative Platinum-Containing Regimen in 116 Patients with Early Triple Negative Breast Cancer. Cancer Invest. 2023 Oct;41(9):789-802. doi: 10.1080/07357907.2023.2278048. Epub 2023 Nov 17. PMID: 37909664.
-
Godson HF, Raj JS, Sebastian P, Ponmalar RY, Babu ES, Paul I, Krishna R, Backianathan S, George B, Ravindran PB, Balakrishnan R. Feasibility study of total marrow lymphoid irradiation with volumetric modulated arc therapy: clinical implementation in a tertiary care center. Strahlenther Onkol. 2023 Oct;199(10):922-935. doi: 10.1007/s00066-023-02100-x. Epub 2023 Jun 6. PMID: 37278833.